Patent expiry dates for biologicals: 2017 update

Category: Special Report
Author(s):
Visits: 123 total, 2 today
Keywords: Biological, Biosimilar, patent
Abstract:
Biosimilars have been approved in Europe since 2006 and in the US since 2015. With patents on originator biologicals expiring and ever-tightening healthcare budgets biosimilars are expected to take an increasing share of the biologicals market. In light of these facts, this article gives estimated patent expiry dates for some of the best-selling biologicals.

Subscribe now to GaBI Journal to view full information of this article to be published in the next journal issue.

Go Back Print

Leave a Reply